EUVIMEDObjevte EUVIMED
Editorial

New Perspectives on Effects of Biologics on Mannitol Airway Hyperresponsiveness

Robert Greig iD, Philipp Suter, Rory Chan, Brian Lipworth iD

Clinical & Experimental Allergy · 2026-03 · 56 (3) · 195-197

DOI: 10.1111/cea.70221 ↗

At a glance

Editorial in Clinical & Experimental Allergy, published online on 2026-01-22. Written by Robert Greig and 3 co-authors. Institution: Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK. Cited 3 times so far (Crossref); 9 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Airway hyperresponsiveness (AHR) is a key tenet in uncontrolled severe asthma and can be used to characterise the potential sensitivity of the airway smooth muscle to external triggers [1], assessed through either direct or indirect challenge. Indirect challenge, which includes mannitol, is more physiological, acting similarly to exogenous stimuli. Mannitol acts to increase osmolarity in the periciliary liquid, which in turn results in both mast cell degranulation and de novo synthesis of bronchocon-stricting mediators. This leads to the release of inflammatory mediators such as histamine or leukotriene D4 alongside the recruitment of eosinophils, which indirectly induce bronchoc-onstriction [1]. This process is demonstrated by the result of sputum eosinophilia to mannitol challenge and therefore reflects the close links between type 2 inflammation and indirect challenge [2]. Bronchoconstriction is measured as the provocation dose (PD) of mannitol required to reduce the FEV1 by either 10% (PD10) or 15% (PD15) and is termed challenge sensitivity, as opposed to reactivity, which is the maximum fall in FEV1 divided by the final cumulative dose of mannitol.

Authors and institutions

  • Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK.

ORCID profiles: Robert Greig, Brian Lipworth

Cite

APA

Greig, R., Suter, P., Chan, R., & Lipworth, B. (2026). New Perspectives on Effects of Biologics on Mannitol Airway Hyperresponsiveness. Clinical & Experimental Allergy, 56(3), 195-197. https://doi.org/10.1111/cea.70221

Vancouver

Greig R, Suter P, Chan R, Lipworth B. New Perspectives on Effects of Biologics on Mannitol Airway Hyperresponsiveness. Clinical & Experimental Allergy. 2026;56(3):195-197. doi:10.1111/cea.70221

BibTeX
@article{Greig2026,
  author = {Greig, Robert and Suter, Philipp and Chan, Rory and Lipworth, Brian},
  title = {New Perspectives on Effects of Biologics on Mannitol Airway Hyperresponsiveness},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {3},
  pages = {195--197},
  doi = {10.1111/cea.70221}
}
Start for free →